If a customer who wanted a coffee received an espresso instead, she might leave the restaurant with only a bad taste in her mouth. But if she were prescribed a biologic drug and received an untested, unknown follow-on, the results could be far worse.
Coffee and espresso aren't the same thing. Congress must recognize that neither are biologics and their follow-ons.
Check out our political cartoons.
Become a political insider: Subscribe to U.S. News Weekly, our new digital magazine.
Corrected on : Bryan A. Liang is executive director of the Institute of Health Law Studies, California Western School of Law, and codirector of the San Diego Center for Patient Safety, University of California-San Diego School of Medicine.